Chasing a ghost? – Issues with the determination of circulating levels of endotoxin in human blood

References

• Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2007;90:859–904
   Web of Science ®Google Scholar
• Benten D, Schulze zur Wiesch J, Sydow K, et al The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS). BMC Gastroenterol 2011;11:107
   PubMed Web of Science ®Google Scholar
• Brun P, Castagliuolo I, Di Leo V, et al Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007;292:G518–25
   PubMed Web of Science ®Google Scholar
• Jacob AI, Goldberg PK, Bloom N, et al Endotoxin and bacteria in portal blood. Gastroenterology 1977;72:1268–70
   PubMed Web of Science ®Google Scholar
• Kaser A, Ludwiczek O, Waldenberger P, et al Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting. Liver 2002;22:380–7
   PubMedGoogle Scholar
• Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988;8:232–6
   PubMed Web of Science ®Google Scholar
• Trent MS, Stead CM, Tran AX, Hankins JV. Diversity of endotoxin and its impact on pathogenesis. J Endotoxin Res 2006;12:205–23
   PubMedGoogle Scholar
• Deopurkar R, Ghanim H, Friedman J, et al Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 2010;33:991–7
   PubMed Web of Science ®Google Scholar
• Ghanim H, Sia CL, Upadhyay M, et al Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am J Clin Nutr 2010;91:940–9
   PubMed Web of Science ®Google Scholar
• Ghoshal S, Witta J, Zhong J, et al Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 2009;50:90–7
   PubMed Web of Science ®Google Scholar
• Laugerette F, Vors C, Géloën A, et al Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutr Biochem 2011;22:53–9
   PubMed Web of Science ®Google Scholar
• Munford RS. Detoxifying endotoxin: time, place and person. J Endotoxin Res 2005;11:69–84
   PubMedGoogle Scholar
• Shao B, Lu M, Katz SC, et al A host lipase detoxifies bacterial lipopolysaccharides in the liver and spleen. J Biol Chem 2007;282:13726–35
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Zawieja S, Wang W, et al Lymphatic system: a vital link between metabolic syndrome and inflammation. Ann N Y Acad Sci 2010;1207:E94–102
   PubMed Web of Science ®Google Scholar
• Iqbal J, Hussain MM. Intestinal lipid absorption. Am J Physiol Endocrinol Metab 2009;296:E1183–94
   PubMed Web of Science ®Google Scholar
• Cani PD, Amar J, Iglesias MA, et al Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761–72
   PubMed Web of Science ®Google Scholar
• Cani PD, Neyrinck AM, Fava F, et al Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007;50:2374–83
   PubMed Web of Science ®Google Scholar
• Cani PD, Possemiers S, Van de Wiele T, et al Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009;58:1091–103
   PubMed Web of Science ®Google Scholar
• Kaliannan K, Hamarneh SR, Economopoulos KP, et al Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci USA 2013;110:7003–8
   PubMed Web of Science ®Google Scholar
• Cani PD, Bibiloni R, Knauf C, et al Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008;57:1470–81
   PubMed Web of Science ®Google Scholar
• Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 2002;71:635–700
   PubMed Web of Science ®Google Scholar
• Tran AX, Whitfield C. Lipopolysaccharides (Endotoxins). Encyclopedia of Microbiology. Third ed. New York: Academic Press, 2009:513–28
   Google Scholar
• Gnauck A, Lentle RG, Kruger MC. The characteristics and function of bacterial lipopolysaccharides and their endotoxic potential in humans. Int Rev Immunol 2015. [ePub ahead of print]. doi:10.3109/08830185.2015.1087518
   PubMedGoogle Scholar
• Brandenburg K, Schromm AB, Gutsmann T. Endotoxins: relationship between structure, function, and activity. Subcell Biochem 2010;53:53–67
   PubMedGoogle Scholar
• Gutsmann T, Howe J, Zähringer U, et al Structural prerequisites for endotoxic activity in the Limulus test as compared to cytokine production in mononuclear cells. Innate Immun 2010;16:39–47
   PubMed Web of Science ®Google Scholar
• Lindberg AA, Weintraub A, Zähringer U, Rietschel ET. Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis. Rev Infect Dis 1990;12Suppl 2:S133–41
   Google Scholar
• Martirosyan A, Ohne Y, Degos C, et al Lipopolysaccharides with acylation defects potentiate TLR4 signaling and shape T cell responses. PloS One 2013;8:e55117
   PubMed Web of Science ®Google Scholar
• Maitra U, Deng H, Glaros T, et al Molecular mechanisms responsible for the selective and low-grade induction of proinflammatory mediators in murine macrophages by lipopolysaccharide. J Immunol 2012;189:1014–23
   PubMed Web of Science ®Google Scholar
• Bates JM, Akerlund J, Mittge E, Guillemin K. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2007;2:371–82
   PubMed Web of Science ®Google Scholar
• Lotz M, Gütle D, Walther S, et al Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med 2006;203:973–84
   PubMed Web of Science ®Google Scholar
• WHO International Standard. 3rd IS for endotoxin. Geneva: WHO, 2013
   Google Scholar
• Thuy S, Ladurner R, Volynets V, et al Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008;2008:8
   Google Scholar
• Volynets V, Küper MA, Strahl S, et al Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD). Dig Dis Sci 2012;57:1932–41
   PubMed Web of Science ®Google Scholar
• Leber B, Tripolt NJ, Blattl D, et al The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study. Eur J Clin Nutr 2012;66:1110–15
   PubMed Web of Science ®Google Scholar
• Creely SJ, McTernan PG, Kusminski CM, et al Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007;292:E740–7
   PubMed Web of Science ®Google Scholar
• Miller MA, McTernan PG, Harte AL, et al Ethnic and sex differences in circulating endotoxin levels: a novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population. Atherosclerosis 2009;203:494–502
   PubMed Web of Science ®Google Scholar
• Pussinen PJ, Havulinna AS, Lehto M, et al Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 2011;34:392–7
   PubMed Web of Science ®Google Scholar
• Al-Attas OS, Al-Daghri NM, Al-Rubeaan K, et al Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc Diabetol 2009;8:20
   PubMed Web of Science ®Google Scholar
• Hawkesworth S, Moore SE, Fulford AJ, et al Evidence for metabolic endotoxemia in obese and diabetic Gambian women. Nutr Diabetes 2013;3:e83
   PubMed Web of Science ®Google Scholar
• Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993;119:771–8
   PubMed Web of Science ®Google Scholar
• Ghanim H, Abuaysheh S, Sia CL, et al Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 2009;32:2281–7
   PubMed Web of Science ®Google Scholar
• Ghanim H, Sia CL, Korzeniewski K, et al A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab 2011;96:1409–14
   PubMed Web of Science ®Google Scholar
• Pastor Rojo O, López San Román A, Albéniz Arbizu E, et al Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm Bowel Dis 2007;13:269–77
   PubMed Web of Science ®Google Scholar
• Albillos A, de la Hera A, González M, et al Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003;37:208–17
   PubMed Web of Science ®Google Scholar
• Basu S, Haghiac M, Surace P, et al Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) 2011;19:476–82
   PubMed Web of Science ®Google Scholar
• Bates DW, Parsonnet J, Ketchum PA, et al Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group. Clin Infect Dis 1998;27:582–91
   PubMed Web of Science ®Google Scholar
• Caradonna L, Amati L, Lella P, et al Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease. Am J Gastroenterol 2000;95:1495–502
   PubMed Web of Science ®Google Scholar
• Ketchum PA, Parsonnet J, Stotts LS, et al Utilization of a chromogenic Limulus amebocyte lysate blood assay in a multi-center study of sepsis. J Endotoxin Res 1997;4:9–16
   Google Scholar
• Monte SV, Caruana JA, Ghanim H, et al Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery 2012;151:587–93
   PubMed Web of Science ®Google Scholar
• Strutz F, Heller G, Krasemann K, et al Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome. Intensive Care Med 1999;25:435–44
   PubMed Web of Science ®Google Scholar
• Danner RL, Elin RJ, Hosseini JM, et al Endotoxemia in human septic shock. Chest 1991;99:169–75
   PubMed Web of Science ®Google Scholar
• Guidet B, Barakett V, Vassal T, et al Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit. Chest 1994;106:1194–201
   PubMed Web of Science ®Google Scholar
• Massignon D, Lepape A, Debize G, et al Detection of gram-negative bacteraemia in early sepsis by a quantitative chromogenic and kinetic endotoxin assay. The Study Group. Eur J Clin Invest 1996;26:596–601
   PubMed Web of Science ®Google Scholar
• Byl B, Clevenbergh P, Kentos A, et al Ceftazidime- and imipenem-induced endotoxin release during treatment of gram-negative infections. Eur J Clin Microbiol Infect Dis 2001;20:804–7
   PubMed Web of Science ®Google Scholar
• Dofferhoff AS, Bom VJ, de Vries-Hospers HG, et al Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992;20:185–92
   PubMed Web of Science ®Google Scholar
• Venet C, Zeni F, Viallon A, et al Endotoxaemia in patients with severe sepsis or septic shock. Intensive Care Med 2000;26:538–44
   PubMed Web of Science ®Google Scholar
• Hurley JC, Guidet B, Offenstadt G, Maury E. Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders. Crit Care 2012;16:R148
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Veterinary Medicine (CVM), Center for Devices and Radiological Health (CDRH), et al Guidance for Industry – Pyrogen and Endotoxins Testing: Questions and Answers. Silver Spring: FDA, 2012
   Google Scholar
• U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration. Guideline on Validation of the Limulus Amebocyte Lysate Test as an End-Product Endotoxin Test for Human and Animal Parenteral Drugs, Biological Products, and Medical Devices. Silver Spring: FDA, 1987
   Google Scholar
• Levin J, Bang FB. The role of endotoxin in the extracellular coagulation of Limulus blood. Bull Johns Hopkins Hosp 1964;002:265–74
   Google Scholar
• Levin J, Bang FB. Clottable protein in Limulus; its localization and kinetics of its coagulation by endotoxin. Thromb Diath Haemorrh 1968;19:186–97
   PubMedGoogle Scholar
• Young NS, Levin J, Prendergast RA. An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation. J Clin Invest 1972;51:1790–7
   PubMed Web of Science ®Google Scholar
• Fink PC, Lehr L, Urbaschek RM, Kozak J. Limulus amebocyte lysate test for endotoxemia: investigations with a femtogram sensitive spectrophotometric assay. Klin Wochenschr 1981;59:213–18
   PubMedGoogle Scholar
• Hurley JC. Endotoxemia: methods of detection and clinical correlates. Clin Microbiol Rev 1995;8:268–92
   PubMed Web of Science ®Google Scholar
• Lonza Walkersville Inc. Manual -– Limulus Amebocyte Lysate (LAL) Kinetic-QCL. Walkersville, MD: Lonza Walkersville Inc, 2014
   Google Scholar
• Iwanaga S, Morita T, Harada T, et al Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins. Haemostasis 1978;7:183–8
   PubMedGoogle Scholar
• Newhall KJ, Diemer GS, Leshinsky N, et al Evidence for endotoxin contamination in plastic Na+-heparin blood collection tube lots. Clin Chem 2010;56:1483–91
   PubMed Web of Science ®Google Scholar
• Redl H, Bahrami S, Leichtfried G, Schlag G. Special collection and storage tubes for blood endotoxin and cytokine measurements. Clin Chem 1992;38:764–5
   PubMed Web of Science ®Google Scholar
• Dawson ME. Interference with the LAL test and how to address it. LAL Update 2005;22:1–5
   Google Scholar
• Sullivan JD Jr, Watson SW. Factors affecting the sensitivity of Limulus lysate. Appl Microbiol 1974;28:1023–6
   PubMedGoogle Scholar
• Gnauck A, Lentle RG, Kruger MC. The Limulus Amebocyte Lysate assay may be unsuitable for detecting endotoxin in blood of healthy female subjects. J Immunol Methods 2015;416:146–56
   PubMed Web of Science ®Google Scholar
• Levin J, Tomasulo PA, Oser RS. Detection of endotoxin in human blood and demonstration of an inhibitor. J Lab Clin Med 1970;75:903–11
   PubMed Web of Science ®Google Scholar
• Hollander A, Heederik D, Versloot P, Douwes J. Inhibition and enhancement in the analysis of airborne endotoxin levels in various occupational environments. Am Ind Hyg Assoc J 1993;54:647–53
   PubMed Web of Science ®Google Scholar
• Hurley JC, Tosolini FA, Louis WJ. Quantitative Limulus lysate assay for endotoxin and the effect of plasma. J Clin Pathol 1991;44:849–54
   PubMed Web of Science ®Google Scholar
• Fukui H, Brauner B, Bode JC, Bode C. Chromogenic endotoxin assay in plasma. Selection of plasma pretreatment and production of standard curves. J Clin Chem Clin Biochem 1989;27:941–6
   PubMedGoogle Scholar
• Charles River Laboratories. Endosafe-PTS Assay Guide. San Diego (CA): Charles River Laboratories
   Google Scholar
• Ditter B, Becker KP, Urbaschek R, Urbaschek B. Quantitative endotoxin determination. Automated kinetic Limulus amebocyte lysate microtiter test with measurement of sample-related interferences. Arzneimittelforschung 1983;33:681–7
   PubMed Web of Science ®Google Scholar
• Fukui H, Matsumoto M, Tsujita S, et al Plasma endotoxin concentration and endotoxin binding capacity of plasma acute phase proteins in cirrhotics with variceal bleeding: an analysis by new methods. J Gastroenterol Hepatol 1994;9:582–6
   PubMed Web of Science ®Google Scholar
• Schumann RR, Leong SR, Flaggs GW, et al Structure and function of lipopolysaccharide binding protein. Science 1990;249:1429–31
   PubMed Web of Science ®Google Scholar
• Pulido D, Nogués MV, Boix E, Torrent M. Lipopolysaccharide neutralization by antimicrobial peptides: a gambit in the innate host defense strategy. J Innate Immun 2012;4:327–36
   PubMed Web of Science ®Google Scholar
• Harris HW, Grunfeld C, Feingold KR, Rapp JH. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 1990;86:696–702
   PubMed Web of Science ®Google Scholar
• Wurfel MM, Kunitake ST, Lichenstein H, et al Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 1994;180:1025–35
   PubMed Web of Science ®Google Scholar
• Elsbach P, Weiss J. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology 1993;187:417–29
   PubMed Web of Science ®Google Scholar
• Marra MN, Thornton MB, Snable JL, et al Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5. Crit Care Med 1994;22:559–65
   PubMed Web of Science ®Google Scholar
• Katz SS, Weinrauch Y, Munford RS, et al Deacylation of lipopolysaccharide in whole Escherichia coli during destruction by cellular and extracellular components of a rabbit peritoneal inflammatory exudate. J Biol Chem 1999;274:36579–84
   PubMed Web of Science ®Google Scholar
• Lamping N, Dettmer R, Schröder NW, et al LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. J Clin Invest 1998;101:2065–71
   PubMed Web of Science ®Google Scholar
• Levine DM, Parker TS, Donnelly TM, et al In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci USA 1993;90:12040–4
   PubMed Web of Science ®Google Scholar
• Pajkrt D, Doran JE, Koster F, et al Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med 1996;184:1601–8
   PubMed Web of Science ®Google Scholar
• Parker TS, Levine DM, Chang JC, et al Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun 1995;63:253–8
   PubMed Web of Science ®Google Scholar
• Opal SM, Palardy JE, Marra MN, et al Relative concentrations of endotoxin-binding proteins in body fluids during infection. Lancet 1994;344:429–31
   PubMed Web of Science ®Google Scholar
• Dandliker WB, Alonso R, de Saussure VA, et al The effect of chaotropic ions on the dissociation of antigen-antibody complexes. Biochemistry 1967;6:1460–7
   PubMed Web of Science ®Google Scholar
• Gustaw KA, Garrett MR, Lee HG, et al Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis. J Neurochem 2008;106:1350–6
   PubMed Web of Science ®Google Scholar
• Petsch D, Deckwer WD, Anspach FB. Proteinase K digestion of proteins improves detection of bacterial endotoxins by the Limulus amebocyte lysate assay: application for endotoxin removal from cationic proteins. Anal Biochem 1998;15:1
   Google Scholar
• Obayashi T. Addition of perchloric acid to blood samples for colorimetric limulus test using chromogenic substrate: comparison with conventional procedures and clinical applications. J Lab Clin Med 1984;104:321–30
   PubMed Web of Science ®Google Scholar
• BioDtech Inc. Accurate Endotoxin Detection in Human Plasma with ESP™. ESP™ Application Notes. Birmingham, AL: BioDtech Inc., 2014;Rev 2(11-13-14)
   Google Scholar
• Lonza Walkersville Inc. Certificate of Analysis, product: Kinetic-QCL 192 Test Kit. Walkersville, MD: Lonza Walkersville Inc., 2014
   Google Scholar
• Hurley JC, Nowak P, Öhrmalm L, et al Endotoxemia as a diagnostic tool for patients with suspected bacteremia caused by gram-negative organisms: a meta-analysis of 4 decades of studies. J Clin Microbiol 2015;53:1183–91
   PubMed Web of Science ®Google Scholar
• Dehus O, Hartung T, Hermann C. Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay. J Endotoxin Res 2006;12:171–80
   PubMedGoogle Scholar
• Devleeschouwer MJ, Cornil MF, Dony J. Studies on the sensitivity and specificity of the Limulus amebocyte lysate test and rabbit pyrogen assays. Appl Environ Microbiol 1985;50:1509–11
   PubMed Web of Science ®Google Scholar
• Mathison JC, Ulevitch RJ. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 1979;123:2133–43
   PubMed Web of Science ®Google Scholar
• Trøseid M, Nestvold TK, Rudi K, et al Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery. Diabetes Care 2013;36:3627–32
   PubMed Web of Science ®Google Scholar
• Amar J, Burcelin R, Ruidavets JB, et al Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008;87:1219–23
   PubMed Web of Science ®Google Scholar
• Yajima Y, Fukuda I, Otsuki M, et al Endotoxemia in liver diseases: detection by a quantitative assay using chromogenic substrate with perchloric acid pretreatment. Tohoku J Exp Med 1985;147:411–9
   PubMed Web of Science ®Google Scholar
• Gardiner KR, Halliday MI, Barclay GR, et al Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 1995;36:897–901
   PubMed Web of Science ®Google Scholar
• Opal SM, Scannon PJ, Vincent JL, et al Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 1999;180:1584–9
   PubMed Web of Science ®Google Scholar
• Hanck C, Rossol S, Böcker U, et al Presence of plasma endotoxin is correlated with tumour necrosis factor receptor levels and disease activity in alcoholic cirrhosis. Alcohol Alcohol 1998;33:606–8
   PubMed Web of Science ®Google Scholar
• Kritselis I, Tzanetakou V, Adamis G, et al The level of endotoxemia in sepsis varies in relation to the underlying infection: impact on final outcome. Immunol Lett 2013;152:167–22
   PubMed Web of Science ®Google Scholar
• Landoni VI, Chiarella P, Martire-Greco D, et al Tolerance to lipopolysaccharide promotes an enhanced neutrophil extracellular traps formation leading to a more efficient bacterial clearance in mice. Clin Exp Immunol 2012;168:153–63
   PubMed Web of Science ®Google Scholar
• del Fresno C, García-Rio F, Gómez-Piña V, et al Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J Immunol 2009;182:6494–507
   PubMed Web of Science ®Google Scholar
• Lu M, Varley AW, Ohta S, et al Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following gram-negative bacterial infection. Cell Host Microbe 2008;4:293–302
   PubMed Web of Science ®Google Scholar
• Matricon J, Barnich N, Ardid D. Immunopathogenesis of inflammatory bowel disease. Self Nonself 2010;1:299–309
   PubMedGoogle Scholar
• Benjamin J, Makharia GK, Ahuja V, et al Intestinal permeability and its association with the patient and disease characteristics in Crohn's disease. World J Gastroenterol 2008;14:1399–405
   PubMed Web of Science ®Google Scholar
• Katz KD, Hollander D, Vadheim CM, et al Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology 1989;97:927–31
   PubMed Web of Science ®Google Scholar
• Teahon K, Smethurst P, Levi AJ, et al Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 1992;33:320–3
   PubMed Web of Science ®Google Scholar
• Vilela EG, Torres HO, Ferrari ML, et al Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects. Braz J Med Biol Res 2008;41:1105–9
   PubMed Web of Science ®Google Scholar
• Wyatt J, Vogelsang H, Hübl W, et al Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993;341:1437–9
   PubMed Web of Science ®Google Scholar
• Funderburg NT, Stubblefield Park SR, Sung HC, et al Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation. Immunology 2013;140:87–97
   PubMed Web of Science ®Google Scholar
• Wellmann W, Fink PC, Benner F, Schmidt FW. Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut 1986;27:814–20
   PubMed Web of Science ®Google Scholar
• Schäfer C, Parlesak A, Schütt C, et al Concentrations of lipopolysaccharide-binding protein, bactericidal/permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease. Alcohol Alcohol 2002;37:81–6
   PubMed Web of Science ®Google Scholar
• Lin RS, Lee FY, Lee SD, et al Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 1995;22:165–72
   PubMed Web of Science ®Google Scholar
• Liu WT, Jing YY, Han ZP, et al The injured liver induces hyperimmunoglobulinemia by failing to dispose of antigens and endotoxins in the portal system. PLoS One 2015;10:e0122739
   Google Scholar
• Tachiyama G, Sakon M, Kambayashi J, et al Endogenous endotoxemia in patients with liver cirrhosis – a quantitative analysis of endotoxin in portal and peripheral blood. Jpn J Surg 1988;18:403–8
   PubMedGoogle Scholar
• Kalambokis GN, Mouzaki A, Rodi M, Tsianos EV. Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia. Liver Int 2012;32:467–75
   PubMed Web of Science ®Google Scholar
• Jin R, Willment A, Patel SS, et al Fructose induced endotoxemia in pediatric nonalcoholic fatty liver disease. Int J Hepatol 2014;2014:560620
   PubMedGoogle Scholar
• Bode C, Schäfer C, Fukui H, Bode JC. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease-a double-blind, placebo-controlled trial. Alcohol Clin Exp Res 1997;21:1367–73
   PubMed Web of Science ®Google Scholar
• Bode C, Fukui H, Bode JC. 'Hidden'endotoxin in plasma of patients with alcoholic liver disease. Eur J Gastroenterol Hepatol 1993;5:257–62
   Web of Science ®Google Scholar
• Parlesak A, Schäfer C, Schütz T, et al Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 2000;32:742–7
   PubMed Web of Science ®Google Scholar
• Fukui H, Matsumoto M, Bode C, et al Endotoxaemia in patients with liver cirrhosis and upper gastrointestinal bleeding: detection by the chromogenic assay with plasma Tween 80 pretreatment. J Gastroenterol Hepatol 1993;8:577–81
   PubMed Web of Science ®Google Scholar
• Fukui H, Brauner B, Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 1991;12:162–9
   PubMed Web of Science ®Google Scholar
• Lee FY, Lu RH, Tsai YT, et al Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation. Scand J Gastroenterol 1996;31:500–5
   PubMed Web of Science ®Google Scholar
• Urbaschek R, McCuskey RS, Rudi V, et al Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease. Alcohol Clin Exp Res 2001;25:261–8
   PubMed Web of Science ®Google Scholar
• Schäfer C, Greiner B, Landig J, et al Decreased endotoxin-binding capacity of whole blood in patients with alcoholic liver disease. J Hepatol 1997;26:567–73
   PubMed Web of Science ®Google Scholar
• Ingoldby CJ, Skinner C, Giles GR. A comparison of methods of removing inhibitors to the chromogenic Limulus assay in normal and jaundiced blood. Thromb Res 1986;44:95–100
   PubMed Web of Science ®Google Scholar
• Clemente-Postigo M, Queipo-Ortuño MI, Murri M, et al Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients. J Lipid Res 2012;53:973–8
   PubMed Web of Science ®Google Scholar
• Harte AL, Varma MC, Tripathi G, et al High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care 2012;35:375–82
   PubMed Web of Science ®Google Scholar
• Moreno-Navarrete JM, Ortega F, Serino M, et al Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. Int J Obes (Lond) 2012;36:1442–9
   PubMed Web of Science ®Google Scholar
• Lira FS, Rosa JC, Pimentel GD, et al Long-term interdisciplinary therapy reduces endotoxin level and insulin resistance in obese adolescents. Nutr J 2012;11:74
   PubMed Web of Science ®Google Scholar
• Lassenius MI, Pietiläinen KH, Kaartinen K, et al Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 2011;34:1809–15
   PubMed Web of Science ®Google Scholar
• Novelli G, Morabito V, Ferretti G, et al Safety of polymyxin-B-based hemoperfusion in kidney and liver transplant recipients. Transplant Proc 2012;44:1966–72
   PubMed Web of Science ®Google Scholar
• Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007;86:1286–2
   PubMed Web of Science ®Google Scholar
• Reed GF, Lynn F, Meade BD. Use of coefficient of variation in assessing variability of quantitative assays. Clin Diagn Lab Immunol 2002;9:1235–9
   PubMedGoogle Scholar
• Spectral Medical Inc. Instruction for Use EAA (Endotoxin Activity Assay). Etobicoke: Spectral Medical Inc
   Google Scholar
• Romaschin AD, Klein DJ, Marshall JC. Bench-to-bedside review: Clinical experience with the endotoxin activity assay. Crit Care 2012;16:248
   PubMed Web of Science ®Google Scholar
• Biagioni E, Venturelli C, Klein DJ, et al Endotoxin activity levels as a prediction tool for risk of deterioration in patients with sepsis not admitted to the intensive care unit: a pilot observational study. J Crit Care 2013;28:612–7
   PubMed Web of Science ®Google Scholar
• Yaroustovsky M, Plyushch M, Popov D, et al Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgery. J Inflamm (Lond) 2013;10:8
   PubMed Web of Science ®Google Scholar
• Arnold R, Schorr C, Trzeciak S, Dellinger RP. Increased endotoxin activity is associated with clinical deterioration in moderate-severity emergency department sepsis patients: a pilot study. Crit Care 2012;16:P102
   PubMed Web of Science ®Google Scholar
• Yaguchi A, Yuzawa J, Klein DJ, et al Combining intermediate levels of the Endotoxin Activity Assay (EAA) with other biomarkers in the assessment of patients with sepsis: results of an observational study. Crit Care 2012;16:R88
   PubMed Web of Science ®Google Scholar
• Pathan N, Burmester M, Adamovic T, et al Intestinal injury and endotoxemia in children undergoing surgery for congenital heart disease. Am J Respir Crit Care Med 2011;184:1261–9
   PubMed Web of Science ®Google Scholar
• Klein DJ, Briet F, Nisenbaum R, et al Endotoxemia related to cardiopulmonary bypass is associated with increased risk of infection after cardiac surgery: a prospective observational study. Crit Care 2011;15:R69
   PubMed Web of Science ®Google Scholar
• Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 2012;142:1100–1.e2
   PubMed Web of Science ®Google Scholar
• Sato M, Matsuyama R, Kadokura T, et al Severity and prognostic assessment of the endotoxin activity assay in biliary tract infection. J Hepatobiliary Pancreat Sci 2014;21:120–7
   PubMed Web of Science ®Google Scholar
• Ponda MP, Breslow JL. Vitamin D3 repletion in chronic kidney disease stage 3: effects on blood endotoxin activity, inflammatory cytokines, and intestinal permeability. Ren Fail 2013;35:497–503
   PubMed Web of Science ®Google Scholar
• Grimaldi D, Guivarch E, Neveux N, et al Markers of intestinal injury are associated with endotoxemia in successfully resuscitated patients. Resuscitation 2013;84:60–5
   PubMed Web of Science ®Google Scholar
• Schumann RR, Kirschning CJ, Unbehaun A, et al The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol 1996;16:3490–503
   PubMed Web of Science ®Google Scholar
• Sun L, Yu Z, Ye X, et al A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 2010;33:1925–32
   PubMed Web of Science ®Google Scholar
• Kim KA, Gu W, Lee IA, et al High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PloS One 2012;7:e47713
   PubMed Web of Science ®Google Scholar
• Liu X, Lu L, Yao P, et al Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: a prospective study among middle-aged and older Chinese. Diabetologia 2014;57:1834–41
   PubMed Web of Science ®Google Scholar
• Stehle JR, Jr, Leng X, Kitzman DW, et al Lipopolysaccharide-binding protein, a surrogate marker of microbial translocation, is associated with physical function in healthy older adults. J Gerontol Biol Sci Med Sci 2012;67:1212–18
   PubMed Web of Science ®Google Scholar
• Myc A, Buck J, Gonin J, et al The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome. Clin Diagn Lab Immunol 1997;4:113–16
   PubMedGoogle Scholar
• Reiberger T, Ferlitsch A, Payer BA, et al Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. J Hepatol 2013;58:911–21
   PubMed Web of Science ®Google Scholar
• Zweigner J, Gramm HJ, Singer OC, et al High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 2001;98:3800–8
   PubMed Web of Science ®Google Scholar
• Chen YY, Lien JM, Peng YS, et al Lipopolysaccharide binding protein in cirrhotic patients with severe sepsis. J Chin Med Assoc 2014;77:68–74
   PubMed Web of Science ®Google Scholar
• Levels JH, Pajkrt D, Schultz M, et al Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis. Biochim Biophys Acta 2007;1771:1429–38
   PubMed Web of Science ®Google Scholar
• Rau B, Steinbach G, Krüger CM, et al Clinical value of lipopolysaccharide-binding protein (LBP) determinations in acute pancreatitis. Langenbecks Arch Surg 2003;55:181–8
   Web of Science ®Google Scholar
• Erwin PJ, Lewis H, Dolan S, et al Lipopolysaccharide binding protein in acute pancreatitis. Crit Care Med 2000;28:104–9
   PubMed Web of Science ®Google Scholar
• Gonzalez-Quintela A, Alonso M, Campos J, et al Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLoS One 2013;8:e5600
   Web of Science ®Google Scholar
• Lakatos PL, Kiss LS, Palatka K, et al Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease. Inflamm Bowel Dis 2011;17:767–77
   PubMed Web of Science ®Google Scholar
• Vors C, Pineau G, Gabert L, et al Modulating absorption and postprandial handling of dietary fatty acids by structuring fat in the meal: a randomized crossover clinical trial. Am J Clin Nutr 2013;97:23–36
   PubMed Web of Science ®Google Scholar
• Aravindhan V, Mohan V, Arunkumar N, et al Chronic endotoxemia in subjects with type-1 diabetes is seen much before the onset of microvascular complications. PLoS One 2015;10:e0137618
   Google Scholar
• Schmid A, Petry N, Walther B, et al Inflammatory and metabolic responses to high-fat meals with and without dairy products in men. Br J Nutr 2015;113:1853–61
   PubMed Web of Science ®Google Scholar
• Watanabe T, Takeuchi T, Handa O, et al A multicenter, randomized, double-blind, placebo-controlled trial of high-dose rebamipide treatment for low-dose aspirin-induced moderate-to-severe small intestinal damage. PLoS One 2015;10:e0122330
   PubMed Web of Science ®Google Scholar
• Fabienne L, Gaelle P, Cecile V, Marie-Caroline M. Endotoxemia analysis by the Limulus amoebocyte lysate assay in different mammal species used in metabolic studies. J Anal Bioanal Tech 2015;6:251
   Google Scholar
• Ishikawa M, Uemura M, Matsuyama T, et al Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia. Alcohol Clin Exp Res 2010;34:S25–33
   PubMed Web of Science ®Google Scholar
• Kelly CJ, Colgan SP, Frank DN. Of microbes and meals: the health consequences of dietary endotoxemia. Nutr Clin Pract 2012;27:215–25
   PubMed Web of Science ®Google Scholar
• Novitsky TJ. Limulus amebocyte lysate (LAL) detection of endotoxin in human blood. J Endotoxin Res 1994;1:253–63
   Google Scholar